Avance Clinical and Julius Clinical Forge Global Partnership to Accelerate Biotech Trials

Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs has signed a Memorandum of Understanding (MOU) with Juli...

May 31, 2024 | Friday | News
European Commission Approves Opdivo® Combination Therapy for First-Line Treatment of Metastatic Urothelial Carcinoma

Bristol Myers Squibb  announced that the European Commission (EC) has approved Opdivo®(nivolumab) in combination with cisplatin and gemcitabine ...

May 30, 2024 | Thursday | News
MilliporeSigma Launches M-Trace® Software & Mobile App to Digitize Sterility Testing for Pharmaceutical Industry

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, has launched its M...

May 29, 2024 | Wednesday | News
lifespin GmbH and Acıbadem University Forge Global Alliance to Spearhead Precision Medicine Revolution

lifespin GmbH, a pioneer in health status detection software, has teamed up with Acıbadem University (ACU) and Acıbadem Healthcare Group (AHG) to launc...

May 28, 2024 | Tuesday | News
OSE Immunotherapeutics and Boehringer Ingelheim Broaden Partnership to Include New CRM and Cancer Therapies

OSE Immunotherapeutics and Boehringer Ingelheim announced a major expansion of their partnership. Two new projects to develop first-in-class treatments wi...

May 22, 2024 | Wednesday | News
YGION Biomedical Secures €15M in Series A Funding to Advance Personalized Cancer Vaccine Technology

YGION Biomedical GmbH, a company dedicated to developing individualized neoantigen-based cancer vaccines, today announced the completion of a Series A fina...

May 21, 2024 | Tuesday | News
Sanofi, Formation Bio, and OpenAI Forge Pioneering Partnership to Transform Drug Development with AI

Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and bring new medicines to patients more eff...

May 21, 2024 | Tuesday | News
AlphaFold 3 Unleashed: Because Who Needs Scientists Anyway?

Google DeepMind and Isomorphic Labs have unveiled AlphaFold 3, a groundbreaking AI model poised to rewrite the rulebook on molecular biology and redefine t...

May 10, 2024 | Friday | News
Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine

  Agreement provides patients with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, fro...

May 10, 2024 | Friday | News
Ribobay Pharma and Cytiva Collaborate to Revolutionize Oligonucleotide Manufacturing

    Ribobay Pharma, a prominent Chinese biopharmaceutical contract research, development, and manufacturing organization (CRDMO), in conjuncti...

May 09, 2024 | Thursday | News
QIAGEN and FBI Join Forces to Pioneer Digital PCR Assay for QIAcuity in Forensic Applications

QIAGEN announced a cooperative research and development agreement (CRADA) with the U.S. Federal Bureau of Investigation (FBI) to develop a novel test for i...

May 08, 2024 | Wednesday | News
CytomX Therapeutics Collaborates with MSD for First-in-Human Trial of Novel CX-801 Cytokine to Revolutionize Cancer Treatment

- CX-801 is a dually masked, conditionally activated IFNα2b cytokine designed using the CytomX Probody® Therapeutic Platform - - Phase 1 first-i...

May 08, 2024 | Wednesday | News
BrightInsight Teams Up with Google Cloud to Transform Patient Care with Advanced AI Solutions

BrightInsight, Inc, the trusted partner and platform driving value for top biopharma compliant digital health solutions, announced today that it will deplo...

May 07, 2024 | Tuesday | News
Walgreens and Boehringer Ingelheim Forge Strategic Partnership to Democratize Clinical Trials

Walgreens and Boehringer Ingelheim announced a strategic collaboration aimed at optimizing recruitment and making clinical trials more accessible, inclusiv...

May 03, 2024 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close